이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Ipca Laboratories 대차 대조표 상태
재무 상태 기준 확인 5/6
Ipca Laboratories 의 총 주주 지분은 ₹77.3B 이고 총 부채는 ₹13.9B, 이는 부채 대 자기자본 비율을 18% 로 가져옵니다. 총자산과 총부채는 각각 ₹111.0B 및 ₹33.7B 입니다. Ipca Laboratories 의 EBIT는 ₹9.6B 이며 이자보상배율은 7 입니다. ₹8.6B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
18.6%
부채 비율
₹14.38b
부채
| 이자 보상 비율 | 14.7x |
| 현금 | ₹8.54b |
| 주식 | ₹77.27b |
| 총 부채 | ₹33.74b |
| 총 자산 | ₹111.01b |
최근 재무 상태 업데이트
Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Jan 09
Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Aug 20Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet
Feb 28Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Sep 20Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Jun 22Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Mar 15Recent updates
Earnings Tell The Story For Ipca Laboratories Limited (NSE:IPCALAB)
Sep 10Ipca Laboratories' (NSE:IPCALAB) Solid Earnings Have Been Accounted For Conservatively
Jun 07Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing
May 24Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings
Feb 07Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Jan 09Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Aug 20Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet
Feb 28Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Sep 20Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)
Aug 31Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Jun 22Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)
May 28Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Mar 15These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well
Sep 20Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?
Aug 09Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Jun 08How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?
Mar 26Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?
Mar 13Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently
Feb 28Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 23Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?
Feb 11Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?
Jan 30The Ipca Laboratories (NSE:IPCALAB) Share Price Is Up 264% And Shareholders Are Boasting About It
Jan 15Ipca Laboratories (NSE:IPCALAB) Seems To Use Debt Rather Sparingly
Dec 31
Don't Ignore The Fact That This Insider Just Sold Some Shares In Ipca Laboratories Limited (NSE:IPCALAB)
Dec 16The Case For Ipca Laboratories Limited (NSE:IPCALAB): Could It Be A Nice Addition To Your Dividend Portfolio?
Dec 13재무 상태 분석
단기부채: IPCALAB 의 단기 자산 ( ₹55.4B )이 단기 부채( ₹23.6B ).
장기 부채: IPCALAB 의 단기 자산( ₹55.4B )이 장기 부채( ₹10.2B ).
부채 대 자본 내역 및 분석
부채 수준: IPCALAB 의 순부채 대 자기자본 비율( 6.9% )은 satisfactory로 간주됩니다.
부채 감소: IPCALAB 의 부채 대 자기자본 비율은 지난 5년간 14.8% 에서 18% 로 증가했습니다.
부채 범위: IPCALAB 의 부채는 영업 현금 흐름 ( 68.1% )에 의해 잘 충당되었습니다.
이자 보장: IPCALAB 의 부채에 대한 이자 지급은 EBIT( 7 x 적용 범위)로 잘 충당됩니다.